Conjunctival Diseases Clinical Trial
Official title:
Measuring the Recovery of the Conjunctival Tissue After 4 Days of Scleral Lens Wear
Verified date | January 2021 |
Source | University of Houston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Scleral lenses, customized rigid contact lenses that land on the soft and spongy conjunctival tissue overlying the sclera, will be fitted on 15 subjects with normal ocular surfaces. The purpose of the study is to determine the amount of conjunctival compression caused by the devices and the length of time required for the shape to recover from compression.
Status | Completed |
Enrollment | 13 |
Est. completion date | May 30, 2020 |
Est. primary completion date | May 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Normal ocular surface without conjunctival or scleral disease - Male or female - 18 years of age and older prior to the initial visit - A non-scleral lens wearer. Exclusion Criteria: - Individuals with anterior segment ocular pathology that may affect intraocular pressure and/or scleral/conjunctival health. - Individuals with known adverse response to FluressĀ® ophthalmic drops - Individuals with a history of habitual scleral lens wear - If a usable baseline image is unable to be obtained at the initial visit due to small ocular surface area or eyelid anatomy - Individuals currently taking any ocular medications that could affect intraocular pressure and/or scleral/conjunctival health - Individuals who have any other conditions or situations which, in the investigator's opinion, may put the subject at significant risk, may confound study outcomes, or may significantly interfere with the subject's participation in the study |
Country | Name | City | State |
---|---|---|---|
United States | University of Houston College of Optometry | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Houston |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rebound at 120 minutes post-SL removal, Day 4 | Conjunctival rebound amount at 120 minutes post-removal, Day 4 | Measured 120-130 minutes post-SL removal, Day 4 | |
Secondary | Rebound at 120-hours post-SL discontinuation | Conjunctival rebound amount at 120 hours post-removal | Measured 115-125 hours post-SL removal | |
Secondary | Rebound at 168-hours post-SL discontinuation | Conjunctival rebound amount at 168 hours post-removal | Measured 160-170 hours post-SL removal | |
Secondary | Rebound at 144-hours post-SL discontinuation | Conjunctival rebound amount at 144 hours post-removal | Measured 140-150 hours post-SL removal | |
Secondary | Rebound at 72-hours post-SL discontinuation | Conjunctival rebound amount at 72 hours post-removal | Measured 60-80 hours post-SL removal | |
Secondary | Rebound at 90 minutes post-SL removal, Day 4 | Conjunctival rebound amount at 90 minutes post-removal, Day 4 | Measured 90-100 minutes post-SL removal, Day 4 | |
Secondary | Rebound at 90 minutes post-SL removal, Day 1 | Conjunctival rebound amount at 90 minutes post-removal, Day 1 | Measured 90-100 minutes post-SL removal, Day 1 | |
Secondary | Rebound at 60 minutes post-SL removal, Day 4 | Conjunctival rebound amount at 60 minutes post-removal, Day 4 | Measured 60-70 minutes post-SL removal, Day 4 | |
Secondary | Rebound at 30 minutes post-SL removal, Day 1 | Conjunctival rebound amount at 30 minutes post-removal, Day 1 | Measured 30-40 minutes post-SL removal, Day 1 | |
Secondary | Rebound at 24-hours post-SL discontinuation | Conjunctival rebound amount at 24 hours post-removal | Measured 20-30 hours post-SL removal | |
Secondary | Rebound at 5 minutes post-SL removal, Day 1 | Conjunctival rebound amount at 5 minutes post-removal, Day 1 | Measured 5-10 minutes post-SL removal, Day 1 | |
Secondary | Rebound at 30 minutes post-SL removal, Day 4 | Conjunctival rebound amount at 30 minutes post-removal, Day 4 | Measured 30-40 minutes post-SL removal, Day 4 | |
Secondary | Rebound at 120 minutes post-SL removal, Day 1 | Conjunctival rebound amount at 120 minutes post-removal, Day 1 | Measured 120-130 minutes post-SL removal, Day 1 | |
Secondary | Rebound at 5 minutes post-SL removal, Day 4 | Conjunctival rebound amount at 5 minutes post-removal, Day 4 | Measured 5-10 minutes post-SL removal, Day 4 | |
Secondary | Rebound at 60 minutes post-SL removal, Day 1 | Conjunctival rebound amount at 60 minutes post-removal, Day 1 | Measured 60-70 minutes post-SL removal, Day 1 | |
Secondary | Rebound at 48-hours post-SL discontinuation | Conjunctival rebound amount at 48 hours post-removal | Measured 40-50 hours post-SL removal | |
Secondary | Rebound at 96-hours post-SL discontinuation | Conjunctival rebound amount at 96 hours post-removal | Measured 90-100 hours post-SL removal |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
Completed |
NCT01250353 -
The Use of Natural Latex Biomembrane in Ocular Surface Reconstruction
|
Phase 2 | |
Completed |
NCT04421300 -
A Randomized Study of Smile Exercise for Dry Eye
|
N/A | |
Not yet recruiting |
NCT04066998 -
Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With Dupilumab
|
N/A | |
Recruiting |
NCT03358979 -
Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
|